Evidence map›Paper›PMID 25289974›Full record

ArticlePloS one2014

Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India.

Avranil Goswami, Urmita Chakraborty, Tanmay Mahapatra, Sanchita Mahapatra, Tapajyoti Mukherjee, Shibali Das, Aritra Das, Subir Kumar Dey, Sudhin Ray, Basudev Bhattacharya and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Article
  4. Article
  5. Observational
  6. Predictors of tuberculosis treatment outcomes among a retrospective cohort in rural, Central India.Journal of clinical tuberculosis and other mycobacterial diseases · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Avranil GoswamiInstitute of Postgraduate Medical Education & Research, Kolkata, India.
Urmita ChakrabortyInstitute of Postgraduate Medical Education & Research, Kolkata, India.
Tanmay MahapatraJonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States of America.
Sanchita MahapatraJonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States of America.
Tapajyoti MukherjeeBurdwan Medical College & Hospital, Burdwan, India.
Shibali DasBose Institute, Kolkata, India.
Aritra DasJonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States of America.
Subir Kumar DeyCalcutta National Medical College, Kolkata, India.
Sudhin RaySSKM Hospital, Kolkata, India.
Basudev BhattacharyaInstitute of Postgraduate Medical Education & Research, Kolkata, India.
Nishith Kumar PalInstitute of Postgraduate Medical Education & Research, Kolkata, India.
Institute of Post Graduate Medical Education and Research · INUniversity of California, Los Angeles · USBose Institute · INBurdwan Medical College & Hospital · INCalcutta National Medical College and Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWorldwide highest number of new pulmonary tuberculosis (PTB) cases, was reported from India in 2012. Adverse treatment outcomes and emergence of drug resistance further complicated the prevailing scenario owing to increased duration, cost and toxicity associated with the treatment of drug-resistant cases. Hence to reinforce India's fight against TB, identification of the correlates of adverse treatment outcomes and drug resistance, seemed critical.

methodsTo estimate the associations between diagnostic findings, patient types (based on treatment outcomes), drug resistance and socio-demographic characteristics of PTB patients, a cross-sectional study was conducted in two tertiary-care hospitals in Kolkata between April 2010 and March 2013. Altogether, 350 consenting Mycobacterium tuberculosis sputum-culture positive PTB patients were interviewed about their socio-demographic background, evaluated regarding their X-ray findings (minimal/moderately advanced/far advanced/cavities), sputum-smear positivity, and treatment history/outcomes (new/defaulter/relapse/treatment-failure cases). Multiple-allele-specific polymerase chain reaction (MAS-PCR) was conducted to diagnose drug resistance.

resultsAmong all participants, 31.43% were newly diagnosed, while 44%, 15.43% and 9.14% patients fell into the categories of relapsed, defaulters and treatment-failures, respectively. 12.29% were multi-drug-resistant (MDR: resistant to at least isoniazid and rifampicin), 57.71% had non-MDR two-drug resistance and 12% had single-drug resistance. Subjects with higher BMI had lower odds of being a relapse/defaulter/treatment failure case while females were more likely to be defaulters and older age-groups had more relapse. Elderly, females, unmarried, those with low BMI and higher grade of sputum-smear positivity were more likely to have advanced X-ray features. Higher grade of sputum-smear positivity and advanced chest X-ray findings were associated with relapse/treatment-failures. Elderly, unmarried, relapse/defaulter/treatment-failure cases had higher odds and those with higher BMI and moderately/far advanced X-ray findings had lower odds of having MDR/non-MDR two-drug resistant PTB.

conclusionTargeted intervention and appropriate counseling are needed urgently to prevent adverse treatment outcomes and development of drug resistance among PTB patients in Kolkata.

Indexed as

Drug Resistance, BacterialAdolescentAdultAge FactorsAntitubercular AgentsCross-Sectional StudiesFemaleHumansIndiaIsoniazidMaleMicrobial Sensitivity TestsMiddle AgedMycobacterium tuberculosisRadiographyRecurrenceAntitubercular AgentsIsoniazidRifampin

Identifiers

PMID25289974
PMCPMC4188738
OpenAlexW2060065602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.